NIDA Support for Drug Interaction Research

Jagjitsingh H. Khalsa, PhD
Center on AIDS and Other Medical Consequences of Drug Abuse (CAMCODA)
National Institute of Drug Abuse, NIH
6001 Executive Blvd., Room 5198, MSC 9593
Bethesda, Maryland
E-mail: jk98p@nih.gov

Dr. Khalsa closed the symposium by inviting attendees to contact him with queries about financial support for research on interactions involving drugs of abuse. NIDA will consider support for both US and non-US researchers. He listed the following examples of research NIDA may support:

• Underlying mechanisms of drug interactions and metabolic pathways
• In-vitro or In-vivo models to study drug-drug interactions
• Factors in and mechanisms of drug induction
• Exploratory clinical pharmacology and diagnostic screening studies
• Interactions between drugs of abuse and pharmacotherapeutics (antiretrovirals, antibiotics) used in the treatment of infections including HIV, hepatitis, and STDs, drug addiction (e.g, methadone, LAAM, buprenorphine), co-morbid mental disorders, and oral contraceptives.

Workshop Homepage

NIDA Home | Site Map | Search | FAQs | Accessibility | Privacy | FOIA (NIH) | Employment | Print Version _ The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH) , a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. Last updated on Monday, May 13, 2002.